×

PRGX Global, Inc. Announces Third Quarter 2012 Financial Results

PRGX Global, Inc. Logo

Operating Highlights

  • Year-over-year revenue growth for the third consecutive quarter and 11 of last 12 quarters
  • Q3 2012 Adjusted EBITDA of $8.8 million represents 27% growth over Q3 2011; 16% growth over Q2 2012
  • YTD 2012 Adjusted EBITDA of $23.2 million represents 29% growth over same period in 2011
  • New Services segment revenue grew 19% over Q3 2011
  • Won third Medicaid agency recovery audit contract

ATLANTA, Oct. 29, 2012 (GLOBE NEWSWIRE) -- PRGX Global, Inc. (Nasdaq:PRGX), the world's leading provider of recovery audit services and the pioneer in Profit Discovery™, today announced its unaudited financial results for the third quarter and nine months ended September 30, 2012.

"I am pleased to report our third consecutive quarter of both sequential and year-over-year growth in revenues and Adjusted EBITDA. The global PRGX team continues to deliver on the promise of Profit Discovery for our clients and for our investors," said Romil Bahl, president and chief executive officer.

"Year-over-year quarterly revenue growth was led by our New Services segment and by our Recovery Audit Services – Americas segment, which increased revenues more than 19% and 7%, respectively. Our third reporting segment, Recovery Audit Services – Europe Asia/Pacific, did not deliver to our expectations, and we are focusing significant management attention to ensure this region performs to its potential," continued Bahl.

"Our bottom line continued to grow faster than the top line, as our Service Delivery Model Redesign program continues to leverage our global operations. We have delivered Adjusted EBITDA growth of 27% compared to the same quarter last year, highlighted by the reduction of cost of revenue from 65.9% to 62.3%. It's worth noting that our New Services segment of Healthcare Claims Recovery Audit and Profit Optimization services reduced absolute cost of revenue while delivering the 19% top line growth," concluded Bahl.

Consolidated Results for Three Months Ended September 30, 2012

Consolidated revenues for the third quarter of 2012 increased 0.6% to $52.1 million compared to $51.8 million in the same prior year period. After adjusting for changes in foreign exchange rates, consolidated revenues for the third quarter of 2012 increased 2.4% compared to the same period in 2011.

Recovery Audit Services – Americas revenues for the third quarter of 2012 increased 7.3% to $33.2 million compared to $31.0 million in the same period in the prior year. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services – Americas revenues for the third quarter increased by 8.8% compared to the same period in 2011.

Recovery Audit Services – Europe Asia/Pacific revenues for the third quarter of 2012 decreased 21.4% to $11.4 million compared to $14.5 million in the same period in the prior year. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services – Europe Asia/Pacific revenues for the third quarter decreased by 18.4% compared to the same period in 2011. These results reflect the adverse impact of both the current European economic climate and audit-specific timing issues.

New Services revenues for the third quarter of 2012 increased 19.0% to $7.4 million compared to $6.3 million in the same period in the prior year. The New Services segment represents Healthcare Claims Recovery Audit services and our Profit Optimization services.

Total cost of revenues for the third quarter of 2012 were $32.5 million, or 62.3% of revenue, compared to $34.1 million, or 65.9% of revenue, in the same period in the prior year. SG&A for the third quarter of 2012 was $13.2 million, or 25.4% of revenue, compared to $12.4 million, or 24.0% of revenue in the third quarter of 2011. Depreciation and amortization expenses were $3.1 million in the third quarter of 2012 compared to $2.7 million in the prior year third quarter.

Net earnings for the third quarter of 2012 were $2.6 million, or $0.10 per basic and diluted share, compared to net earnings of $0.4 million, or $0.02 per basic and diluted share, for the same period in 2011. Net cash provided by operating activities for the third quarter of 2012 was $11.5 million compared to $2.6 million in the third quarter of 2011. Working capital improvements since June 30, 2012 accounted for $4.5 million of the third quarter 2012 cash increase. Third quarter 2011 results included working capital changes that used $3.4 million of cash. Cash generated from operations before working capital changes amounted to $7.0 million in the 2012 third quarter, a $1.1 million increase from the same period in 2011.

Adjusted EBITDA for the third quarter of 2012 was $8.8 million compared to $6.9 million of Adjusted EBITDA for the same period in 2011. The 2012 third quarter Adjusted EBITDA was earnings before interest, taxes, depreciation and amortization (EBITDA) excluding a charge of $1.8 million related to stock-based compensation, $0.5 million of transformation severance and related expenses, a $0.1 million charge for acquisition obligations classified as compensation, and $0.3 million of foreign currency gains on intercompany balances. The comparable Adjusted EBITDA amount for the third quarter of 2011 excludes from EBITDA for such period a $1.5 million charge for stock-based compensation, $0.2 million of transformation severance and related expenses, a $0.1 million charge for acquisition obligations classified as compensation and $1.1 million of foreign currency losses on intercompany balances. Schedule 3 attached to this press release provides a reconciliation of net earnings to each of EBIT (earnings before interest and taxes), EBITDA and Adjusted EBITDA.

Consolidated Results for Nine Months Ended September 30, 2012

Consolidated revenues for the nine months ended September 30, 2012 increased 1.4% to $155.4 million compared to $153.2 million in the same prior year period. After adjusting for changes in foreign exchange rates, consolidated revenues for the nine months ended September 30, 2012 increased 3.6% compared to the same period in 2011.

Recovery Audit Services – Americas revenues for the nine months ended September 30, 2012 increased 4.1% to $91.6 million compared to $88.0 million in the same period in the prior year. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services – Americas revenues for the nine month period increased by 5.8% compared to the same period in 2011.

Recovery Audit Services – Europe Asia/Pacific revenues for the nine months ended September 30, 2012 decreased 13.1% to $39.1 million compared to $45.0 million in the same period in the prior year. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services – Europe Asia/Pacific revenues for the nine month period decreased by 9.3% compared to the same period in 2011. As was the case for the third quarter, revenues for the first nine months of 2012 were adversely impacted by both the current European economic climate and audit-specific timing issues.

New Services revenues for the nine months ended September 30, 2012 increased 22.2% to $24.6 million compared to $20.2 million in the same period in the prior year.

Total cost of revenues for the nine months ended September 30, 2012 were $100.0 million, or 64.3% of revenue, compared to $103.2 million, or 67.4% of revenue, in the same period in the prior year. SG&A for the nine months ended September 30, 2012 was $38.6 million, or 24.8% of revenue, compared to $37.1 million, or 24.2% of revenue in the same period in the prior year. Depreciation and amortization expenses were $10.0 million for the nine months ended September 30, 2012 compared to $7.4 million in the same period in the prior year. The increases in depreciation and amortization expenses are primarily attributable to the additional amortization charges resulting from the BSI acquisition in December 2011 and associate migrations in the UK completed in January and June of 2012.

Net earnings for the nine months ended September 30, 2012 were $3.9 million, or $0.15 per basic and diluted share, compared to net earnings of $1.5 million, or $0.06 per basic and diluted share, for the same period in 2011. Net cash provided by operating activities for the nine months ended September 30, 2012 was $12.4 million compared to $12.7 million in the same period last year.

Adjusted EBITDA for the nine months ended September 30, 2012 was $23.2 million compared to $18.1 million of Adjusted EBITDA for the same period in 2011. The nine months ended September 30, 2012 Adjusted EBITDA was earnings before interest, taxes, depreciation and amortization (EBITDA) excluding a charge of $4.5 million related to stock-based compensation, $1.0 million of transformation severance and related expenses, a $0.3 million charge for acquisition obligations classified as compensation, $0.6 million in costs relating to an overtime pay claim, and $0.2 million of foreign currency gains on intercompany balances. The comparable Adjusted EBITDA amount for the nine months ended September 30, 2011 excludes from EBITDA for such period a $3.7 million charge for stock-based compensation, $1.3 million of transformation severance and related expenses, a $0.3 million charge for acquisition obligations classified as compensation and $0.2 million of foreign currency losses on intercompany balances. Schedule 3 attached to this press release provides a reconciliation of net earnings to each of EBIT, EBITDA and Adjusted EBITDA.

Liquidity

At September 30, 2012, the Company had unrestricted cash and cash equivalents of $19.9 million and had no borrowings against its revolving credit facility. Bank debt outstanding at quarter end was $6.8 million, which represented the outstanding balance on a variable rate term loan due quarterly through 2014.

Third Quarter Earnings Call

As previously announced, management will hold a conference call tomorrow morning at 8:30 AM (Eastern time) to discuss the Company's third quarter 2012 financial results. To access the conference call, listeners in the U.S. and Canada should dial (877) 755-7423 at least 5 minutes prior to the start of the conference. Listeners outside the U.S. and Canada should dial (678) 894-3069. To be admitted to the call, listeners should use passcode 41146141.

This teleconference will also be audiocast on the Internet at www.prgx.com (click on "Events & Presentations" under "Investors"). A replay of the audiocast will be available at the same location beginning approximately two hours after the conclusion of the live audiocast, extending through January 31, 2013. Please note that the Internet audiocast is "listen-only." Microsoft Windows Media Player is required to access the live audiocast and the replay. Media Player can be downloaded from www.microsoft.com/windows/mediaplayer.

About PRGX Global, Inc.

Headquartered in Atlanta, Georgia, PRGX Global, Inc. is the world's leading provider of recovery audit services. With over 1,600 employees, the Company operates and serves clients in more than 30 countries and provides its services to over 75% of the top 30 global retailers. PRGX is also pioneering Profit Discovery™, a unique combination of audit, analytics and advisory services that improves client financial performance. For additional information, please visit PRGX at www.prgx.com.

Non-GAAP Financial Measures

EBIT, EBITDA and Adjusted EBITDA are all "non-GAAP financial measures" presented as supplemental measures of the Company's performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating its performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to Adjusted EBITDA is used in the restrictive covenants contained in the Company's secured credit facility. However, EBIT, EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of the Company's results as reported under GAAP. In addition, in evaluating EBIT, EBITDA and Adjusted EBITDA, you should be aware that, as described above, the adjustments may vary from period to period and in the future the Company will incur expenses such as those used in calculating these measures. The Company's presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. Schedule 3 to this press release provides a reconciliation of net earnings to each of EBIT, EBITDA and Adjusted EBITDA.

Forward-Looking Statements

In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company's financial condition and revenue and Adjusted EBITDA growth, and the success of its growth strategies and expansion into new markets.Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company's future performance include revenues that do not meet expectations or justify costs incurred, the Company's ability to develop material sources of new revenue in addition to revenues from its core recovery audit services, changes in the market for the Company's services, the Company's ability to retain and attract qualified personnel, changes to Medicare and Medicaid recovery audit contractor programs, the Company's ability to integrate recent and future acquisitions, uncertainty in the credit markets, the Company's ability to maintain compliance with its financial covenants, client bankruptcies, loss of major clients, and other risks generally applicable to the Company's business. For a discussion of other risk factors that may impact the Company's business, please see the Company's filings with the Securities and Exchange Commission, including its Form 10-K filed on March 15, 2012. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

SCHEDULE 1
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Income
(Amounts in thousands, except per share data)
(Unaudited)
Three Months Nine Months
Ended September 30, Ended September 30,
2012 2011 2012 2011
Revenues $ 52,087 $ 51,751 $ 155,394 $153,173
Operating expenses:
Cost of revenues 32,461 34,125 99,991 103,242
Selling, general and administrative expenses 13,242 12,417 38,575 37,144
Depreciation of property and equipment 1,716 1,464 4,808 3,859
Amortization of intangible assets 1,431 1,277 5,217 3,527
Total operating expenses 48,850 49,283 148,591 147,772
Operating income 3,237 2,468 6,803 5,401
Foreign currency transaction (gains) losses on short-term intercompany balances (348) 1,055 (190) 176
Interest expense, net 515 398 1,548 1,223
Earnings before income taxes 3,070 1,015 5,445 4,002
Income tax expense 505 593 1,586 2,498
Net earnings $ 2,565 $ 422 $ 3,859 $ 1,504
Basic earnings per common share $ 0.10 $ 0.02 $ 0.15 $ 0.06
Diluted earnings per common share $ 0.10 $ 0.02 $ 0.15 $ 0.06
Weighted average common shares outstanding:
Basic 25,541 24,744 25,370 24,510
Diluted 26,250 25,213 25,942 24,901
SCHEDULE 2
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Amounts in thousands)
(Unaudited)
September 30, December 31,
2012 2011
ASSETS
Current assets:
Cash and cash equivalents $ 19,863 $ 20,337
Restricted cash 123 64
Receivables:
Contract receivables, net 45,020 40,624
Employee advances and miscellaneous receivables, net 1,247 1,343
Total receivables 46,267 41,967
Prepaid expenses and other current assets 4,437 5,594
Total current assets 70,690 67,962
Property and equipment, net 19,622 18,586
Goodwill 13,912 13,194
Intangible assets, net 19,719 23,406
Deferred income taxes 901 831
Other assets 2,175 2,434
Total assets $ 127,019 $ 126,413
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $ 14,736 $ 15,035
Accrued payroll and related expenses 20,422 21,920
Refund liabilities and deferred revenue 8,078 8,434
Current portion of debt 3,000 3,000
Business acquisition obligations 3,822 3,502
Total current liabilities 50,058 51,891
Long-term debt 3,750 6,000
Noncurrent business acquisition obligations 3,319 5,604
Other long-term liabilities 3,021 3,828
Total liabilities 60,148 67,323
Shareholders' equity:
Common stock 254 251
Additional paid-in capital 577,755 574,266
Accumulated deficit (514,733) (518,592)
Accumulated other comprehensive income 3,595 3,165
Total shareholders' equity 66,871 59,090
Total liabilities and shareholders' equity $ 127,019 $ 126,413
SCHEDULE 3
PRGX Global, Inc. and Subsidiaries
Reconciliation of Net Earnings to EBIT, EBITDA and Adjusted EBITDA
(Amounts in thousands)
(Unaudited)
Three Months Nine Months
Ended September 30, Ended September 30,
2012 2011 2012 2011
Reconciliation of net earnings to EBIT, EBITDA and Adjusted EBITDA:
Net earnings $ 2,565 $ 422 $ 3,859 $ 1,504
Income tax expense 505 593 1,586 2,498
Interest expense, net 515 398 1,548 1,223
EBIT 3,585 1,413 6,993 5,225
Depreciation of property and equipment 1,716 1,464 4,808 3,859
Amortization of intangible assets 1,431 1,277 5,217 3,527
EBITDA 6,732 4,154 17,018 12,611
Foreign currency transaction (gains) losses on short-term intercompany balances (348) 1,055 (190) 176
Acquisition obligations classified as compensation 93 106 288 334
Transformation severance and related expenses 518 170 1,036 1,267
Costs for overtime pay claim -- -- 577 --
Stock-based compensation 1,839 1,461 4,479 3,663
Adjusted EBITDA $ 8,834 $ 6,946 $ 23,208 $ 18,051
EBIT, EBITDA and Adjusted EBITDA are all "non-GAAP financial measures" presented as supplemental measures of our performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating the Company's performance over time, and that the rating agencies and a number of lenders use EBIT, EBITDA and similar measures for similar purposes. In addition, a measure similar to Adjusted EBITDA is used in the restrictive covenants contained in the Company's secured credit facility. However, EBIT, EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under GAAP. In addition, in evaluating EBIT, EBITDA and Adjusted EBITDA, you should be aware that in the future we will incur expenses such as those used in calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.
SCHEDULE 4
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
(Unaudited)
Three Months Nine Months
Ended September 30, Ended September 30,
2012 2011 2012 2011
Cash flows from operating activities:
Net earnings $ 2,565 $ 422 $ 3,859 $ 1,504
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization 3,147 2,741 10,025 7,386
Amortization of deferred debt costs 46 45 137 136
Stock-based compensation expense 1,839 1,461 4,479 3,663
Foreign currency transaction (gains) losses on short-term intercompany balances (348) 1,055 (190) 176
Decrease (increase) in receivables 1,076 (434) (3,720) (2,172)
Increase (decrease) in accounts payable, accrued payroll and other accrued expenses 3,314 (3,713) (2,352) 3,135
Other, primarily changes in assets and liabilities (144) 983 127 (1,085)
Net cash provided by operating activities 11,495 2,560 12,365 12,743
Cash flows used in investing activities:
Business acquisitions -- (663) (1,437) (663)
Purchases of property and equipment, net of disposals (1,469) (1,863) (5,689) (6,090)
Net cash used in investing activities (1,469) (2,526) (7,126) (6,753)
Net cash used in financing activities (2,223) (2,257) (6,002) (4,443)
Effect of exchange rates on cash and cash equivalents 223 (1,185) 289 (499)
Net increase (decrease) in cash and cash equivalents 8,026 (3,408) (474) 1,048
Cash and cash equivalents at beginning of period 11,837 22,904 20,337 18,448
Cash and cash equivalents at end of period $ 19,863 $ 19,496 $ 19,863 $ 19,496
SCHEDULE 5
PRGX Global, Inc. and Subsidiaries
Results by Operating Segment *
(Amounts in thousands)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
2012 2011 Change 2012 2011 Change
Revenues
Recovery Audit Services - Americas $ 33,235 $ 30,980 $ 2,255 $ 91,640 $ 87,994 $ 3,646
Recovery Audit Services - Europe/Asia-Pacific 11,406 14,516 (3,110) 39,122 45,021 (5,899)
New Services 7,446 6,255 1,191 24,632 20,158 4,474
Total $ 52,087 $ 51,751 $ 336 $ 155,394 $ 153,173 $ 2,221
Cost of revenues
Recovery Audit Services - Americas $ 16,854 $ 16,755 $ (99) $ 48,876 $ 48,995 $ 119
Recovery Audit Services - Europe/Asia-Pacific 9,314 10,988 1,674 30,395 34,646 4,251
New Services 6,293 6,382 89 20,720 19,601 (1,119)
Total $ 32,461 $ 34,125 $ 1,664 $ 99,991 $ 103,242 $ 3,251
Selling, general and administrative expenses
Recovery Audit Services - Americas $ 4,624 $ 4,641 $ 17 $ 14,711 $ 14,669 $ (42)
Recovery Audit Services - Europe/Asia-Pacific 1,502 942 (560) 3,621 3,503 (118)
New Services 1,084 1,124 40 3,997 3,690 (307)
Corporate 6,032 5,710 (322) 16,246 15,282 (964)
Total $ 13,242 $ 12,417 $ (825) $ 38,575 $ 37,144 $ (1,431)
Depreciation of property and equipment
Recovery Audit Services - Americas $ 1,111 $ 963 $ (148) $ 3,016 $ 2,506 $ (510)
Recovery Audit Services - Europe/Asia-Pacific 90 96 6 217 279 62
New Services 515 405 (110) 1,575 1,074 (501)
Total $ 1,716 $ 1,464 $ (252) $ 4,808 $ 3,859 $ (949)
Amortization of intangible assets
Recovery Audit Services - Americas $ 767 $ 575 $ (192) $ 3,120 $ 1,719 $ (1,401)
Recovery Audit Services - Europe/Asia-Pacific�� 462 488 26 1,491 1,160 (331)
New Services 202 214 12 606 648 42
Total $ 1,431 $ 1,277 $ (154) $ 5,217 $ 3,527 $ (1,690)
Operating income (loss)
Recovery Audit Services - Americas $ 9,879 $ 8,046 $ 1,833 $ 21,917 $ 20,105 $ 1,812
Recovery Audit Services - Europe/Asia-Pacific 38 2,002 (1,964) 3,398 5,433 (2,035)
New Services (648) (1,870) 1,222 (2,266) (4,855) 2,589
Corporate (6,032) (5,710) (322) (16,246) (15,282) (964)
Total $ 3,237 $ 2,468 $ 769 $ 6,803 $ 5,401 $ 1,402
Adjusted EBITDA
Recovery Audit Services - Americas $ 12,002 $ 9,766 $ 2,236 $ 28,988 $ 25,449 $ 3,539
Recovery Audit Services - Europe/Asia-Pacific 863 2,574 (1,711) 5,457 7,020 (1,563)
New Services 162 (1,145) 1,307 530 (2,799) 3,329
Corporate (4,193) (4,249) 56 (11,767) (11,619) (148)
Total $ 8,834 $ 6,946 $ 1,888 $ 23,208 $ 18,051 $ 5,157
*The Recovery Audit Services - Americas segment represents recovery audit services, excluding New Services, provided in the United States, Canada and Latin America. The Recovery Audit Services - Europe/Asia-Pacific segment represents recovery audit services provided in Europe, Asia and the Pacific region. The New Services segment represents Healthcare Claims Recovery Audit services and Profit Optimization services.
CONTACT: PRGX Global, Inc. investor-relations@prgx.com Phone: 770-779-3011

Source:PRGX Global, Inc.